Ask about strategies to minimize gastrointestinal symptoms during dose escalation
That conditional language reflects the fact that eligibility and treatment decisions are individualized
A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
As of late February 2025, nine Vanguard funds had five-star ratings
Understanding your peptide genetic profile means your PlexusDx provider can recommend tirzepatide specifically if your genetics suggest good tolerability, or suggest an alternative like semaglutide if your profile indicates higher GI sensitivity
doi: 10.2337/db14-0302 37 BurmeisterMAAyalaJDruckerDJAyalaJE